The market has always priced FPH highly, who have a history of largely delivering with growth. Bit like MFT, EBO, RYM (in the past) never looked like value but delivered to justify their price.

Now with Covid, a large tail winds, and despite a huge increase in profit, the love affair seems over??? Or has it just cooled a bit?